What are the top 20 priciest Medicare prescription drugs?
By The Associated Press, Associated Press
Jul 24, 2016 6:55 AM CDT

A look at Medicare's top 20 priciest prescription drugs in 2015, ranked by their cost above the program's "catastrophic" coverage threshold. Medicare's catastrophic protection kicks in after a beneficiary has spent a given amount of their own money, $4,850 this year. The beneficiary pays only 5 percent, while their insurer pays 15 percent, and taxpayers cover 80 percent. Catastrophic spending is a large and growing share of total costs, threatening to make Medicare's popular prescription plan financially unsustainable.

Drug NameUsesCost
HarvoniHepatitis C$6.3 billion
RevlimidCancer$1.7 billion
SovaldiHepatitis C$1.2 billion
CopaxoneMultiple sclerosis$1.1 billion
GleevecCancer$1 billion
Humira PenRheumatoid arthritis$886 million
TecfideraMultiple sclerosis$724 million
RenvelaKidney disease$675 million
XtandiProstate Cancer$633 million
Lantus SolostarDiabetes$633 million
ZytigaProstate cancer$623 million
Enbrel SureclickRheumatoid arthritis$586 million
AbilifyMental illness$555 million
SensiparKidney disease$533 million
TruvadaHIV$525 million
AripiprazoleMental illness$504 million
LantusDiabetes$484 million
ImbruvicaCancer$473 million
H.P. ActharMultiple sclerosis$467 million
LyricaSeizures$461 million

Some medications have additional uses.

Cost above catastrophic threshold in 2015; includes spending by taxpayers, insurers and beneficiaries.

Source: Centers for Medicare and Medicaid Services, Office of the Actuary